Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Animal models for the study of hepatitis C virus infection and related liver disease.

Bukh J.

Gastroenterology. 2012 May;142(6):1279-1287.e3. doi: 10.1053/j.gastro.2012.02.016. Review.

PMID:
22537434
2.

Experimental models for hepatitis C viral infection.

Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL.

Hepatology. 2009 Nov;50(5):1646-55. doi: 10.1002/hep.23138. Review.

PMID:
19670425
3.

HCV research and anti-HCV drug discovery: toward the next generation.

Wakita T.

Adv Drug Deliv Rev. 2007 Oct 10;59(12):1196-9. Epub 2007 Aug 25.

PMID:
17905463
4.

HCV-hepatocellular carcinoma: new findings and hope for effective treatment.

Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.

Microsc Res Tech. 2005 Nov;68(3-4):130-48. Review.

PMID:
16276514
5.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
6.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
7.

Pathogenesis, diagnosis and management of hepatitis C.

Boyer N, Marcellin P.

J Hepatol. 2000;32(1 Suppl):98-112. Review.

PMID:
10728798
8.

Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

Liang TJ, Heller T.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S62-71. Review.

PMID:
15508105
9.

Innate and adaptive immune responses in HCV infections.

Heim MH, Thimme R.

J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. Review.

10.

Development of humanized mice for the study of hepatitis C virus infection.

Turrini P, Sasso R, Germoni S, Marcucci I, Celluci A, Di Marco A, Marra E, Paonessa G, Eutropi A, Laufer R, Migliaccio G, Padron J.

Transplant Proc. 2006 May;38(4):1181-4.

PMID:
16757300
11.

[Hepatitis C virus infection in renal diseases: state of knowledge, therapeutic problems and perspectives].

Stachowski J.

Pol Merkur Lekarski. 2000 Apr;8(46):303-6. Review. Polish.

PMID:
10897663
12.

Basal replication of hepatitis C virus in nude mice harboring human tumor.

Labonté P, Morin N, Bowlin T, Mounir S.

J Med Virol. 2002 Mar;66(3):312-9.

PMID:
11793382
13.

Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.

Chung RT, He W, Saquib A, Contreras AM, Xavier RJ, Chawla A, Wang TC, Schmidt EV.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9847-52. Epub 2001 Aug 7.

14.

Hepatocellular carcinoma xenograft supports HCV replication: a mouse model for evaluating antivirals.

Hazari S, Hefler HJ, Chandra PK, Poat B, Gunduz F, Ooms T, Wu T, Balart LA, Dash S.

World J Gastroenterol. 2011 Jan 21;17(3):300-12. doi: 10.3748/wjg.v17.i3.300.

15.

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization.

Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7792-6.

16.

Emerging therapeutic strategies for hepatitis C virus infection.

Sato K, Takagi H, Ichikawa T, Kakizaki S, Mori M.

Curr Mol Pharmacol. 2008 Jun;1(2):130-50. Review.

PMID:
20021428
17.

Chronic hepatitis C.

Sharara AI.

South Med J. 1997 Sep;90(9):872-7. Review.

PMID:
9305294
18.

HCV animal models and liver disease.

Vercauteren K, de Jong YP, Meuleman P.

J Hepatol. 2014 Nov;61(1 Suppl):S26-33. doi: 10.1016/j.jhep.2014.07.013. Epub 2014 Nov 3. Review.

19.

Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.

Yamashita T, Honda M, Kaneko S.

J Gastroenterol Hepatol. 2011 Jun;26(6):960-4. doi: 10.1111/j.1440-1746.2011.06723.x. Review.

PMID:
21443660
20.

Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.

Encke J, Radunz W, Eisenbach C, Geib J, Gehrke S, Pfaff E, Stremmel W.

Eur J Clin Invest. 2007 May;37(5):396-406.

PMID:
17461986

Supplemental Content

Support Center